PHARMACOKINETIC STUDIES OF ORAL L-THREO-3,4-DIHYDROXYPHENYLSERINE IN NORMAL SUBJECTS AND PATIENTS WITH FAMILIAL AMYLOID POLYNEUROPATHY

被引:39
作者
SUZUKI, T
HIGA, S
SAKODA, S
UEJI, M
HAYASHI, A
TAKABA, Y
NAKAJIMA, A
机构
[1] NAKAJIMA MED CLIN,ARAO CITY,KUMAMOTO,JAPAN
[2] ARAO CITY HOSP,ARAO CITY,KUMAMOTO,JAPAN
关键词
D O I
10.1007/BF00605999
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:463 / 468
页数:6
相关论文
共 18 条
[1]   PRESSOR EFFECT OF L-THREO-3,4-DIHYDROXYPHENYLSERINE IN RATS [J].
ARAKI, H ;
TANAKA, C ;
FUJIWARA, H ;
NAKAMURA, M ;
OHMURA, I .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (12) :772-777
[2]   AMINO ACIDS OF SERUM AND URINE IN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY [J].
ARAKI, S ;
MAWATARI, S ;
INOKUCHI, T .
ARCHIVES OF NEUROLOGY, 1970, 23 (01) :9-&
[3]   APPROXIMATE SIGNIFICANCE LEVELS OF BEHRENS-FISHER TEST [J].
COCHRAN, WG .
BIOMETRICS, 1964, 20 (01) :191-&
[4]  
DENGLER H, 1957, ARCH EXP PATHOL PH, V232, P324
[5]   URINARY OUTPUT OF CATECHOLAMINES IN NARCOLEPSY UNDER RESTING CONDITIONS AND FOLLOWING ADMINISTRATION OF DOPAMINE DOPA AND DOPS [J].
GUNNE, LM ;
LIDVALL, HF .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1966, 18 (04) :425-+
[6]  
HIGA S, 1980, P JPN SOC MASS SPECT, V5, P165
[7]   BIOLOGICAL TRANSPORT [J].
HOKIN, LE ;
HOKIN, MR .
ANNUAL REVIEW OF BIOCHEMISTRY, 1963, 32 :553-+
[8]  
IMAI K, 1971, CHEM PHARM BULL, V19, P439
[9]   INHIBITORY EFFECT OF (+)THREO-3,4-DIHYDROXYPHENYLSERINE (DOPS) ON DECARBOXYLATION OF (-)THREO-DOPS [J].
INAGAKI, C ;
FUJIWARA, H ;
TANAKA, C .
JAPANESE JOURNAL OF PHARMACOLOGY, 1976, 26 (03) :380-382
[10]  
INAGAKI C, 1978, BIOCHEM PHARMACOL, V27, P1081